These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 2944291)
1. [Active hepatitis B immunization--current status of development and effectiveness]. Baumgarten R; Fengler JD Z Arztl Fortbild (Jena); 1986; 80(10):393-4. PubMed ID: 2944291 [No Abstract] [Full Text] [Related]
4. Two-year study of passive-active immunization for prevention of hepatitis B infection in newborns. Theppisai U; Thanuntaseh C; Chiewsilp P; Siripoonya P J Med Assoc Thai; 1988 Aug; 71(8):413-6. PubMed ID: 2978040 [No Abstract] [Full Text] [Related]
5. [Clinical and serological evaluation of preventive vaccination of volunteers of the high risk group with hepatitis B vaccine]. Brzosko WJ; Laskowski ZK; Bańkowski A; Janicki P; Dabrowa A; Tkacz B; Gall W Pol Tyg Lek; 1986 Jul; 41(28):893-5. PubMed ID: 2945170 [No Abstract] [Full Text] [Related]
6. Recombinant hepatitis B vaccine. Med Lett Drugs Ther; 1986 Dec; 28(728):118-9. PubMed ID: 2946924 [No Abstract] [Full Text] [Related]
7. [Current status and outlook of the artificial-active immunoprophylaxis of viral hepatitis B]. Ivan A; Mitroi I Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):455-8. PubMed ID: 3074433 [No Abstract] [Full Text] [Related]
8. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine]. Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076 [No Abstract] [Full Text] [Related]
9. [Serologic indicators of the preventive activity of gamma globulin produced by the Warsaw Laboratory of Sera and Vaccines in 1972-1984 against viral hepatitis]. Karwowska S; Kacperska E; Seyfried H; Nowosławski A Przegl Epidemiol; 1986; 40(2):193-9. PubMed ID: 2433711 [No Abstract] [Full Text] [Related]
10. [Importance of controlling immunity after vaccination against hepatitis B]. Eriksson I; Mares I Lakartidningen; 1989 Mar; 86(9):705. PubMed ID: 2522161 [No Abstract] [Full Text] [Related]
11. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects. Ristola MA; Vuola JM; Valle M; von Reyn CF Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038 [TBL] [Abstract][Full Text] [Related]
12. Developments in immunization against hepatitis B. Zuckerman AJ Ann Ist Super Sanita; 1987; 24(2):285-91. PubMed ID: 2969206 [No Abstract] [Full Text] [Related]
13. Hepatitis B vaccine: issues, recommendations, and new developments. Stevens CE; Taylor PE Semin Liver Dis; 1986 Feb; 6(1):23-7. PubMed ID: 2940687 [No Abstract] [Full Text] [Related]
14. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen. Frazer IH; Jones B; Dimitrakakis M; Mackay IR Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303 [TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B vaccination in dialysis patients: reversibility of defective immune response by simultaneous administration of interleukin 2]. Zeitz M Z Gastroenterol; 1990 Mar; 28(3):179-80. PubMed ID: 2140478 [No Abstract] [Full Text] [Related]
19. Low dose hepatitis B vaccination in children: benefit of low dose boosters. Milne A; Moyes CD; Dimitrakakis M N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and side effects of low dose intradermally administered hepatitis B vaccine. Pathak UN; Dilawari JB; Chawla Y; Sokhey CS; Sharma BK; Ganguly NK Indian J Gastroenterol; 1988 Apr; 7(2):113-4. PubMed ID: 2966113 [No Abstract] [Full Text] [Related] [Next] [New Search]